560 related articles for article (PubMed ID: 29465360)
1. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease.
Handa T; Matsui S; Yoshifuji H; Kodama Y; Yamamoto H; Minamoto S; Waseda Y; Sato Y; Kubo K; Mimori T; Chiba T; Hirai T; Mishima M
Mod Rheumatol; 2018 Sep; 28(5):838-844. PubMed ID: 29251035
[TBL] [Abstract][Full Text] [Related]
3. Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease.
Karim AF; Eurelings LEM; Bansie RD; van Hagen PM; van Laar JAM; Dik WA
Mediators Inflamm; 2018; 2018():6103064. PubMed ID: 29686532
[TBL] [Abstract][Full Text] [Related]
4. Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.
Jülich M; Kanne AM; Sehnert B; Budweiser S; Voll RE; Kollert F
Clin Rheumatol; 2018 Sep; 37(9):2361-2366. PubMed ID: 29858711
[TBL] [Abstract][Full Text] [Related]
5. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
6. The clinical characteristics of patients with IgG4-related disease with infiltration of the labial salivary gland by IgG4-positive cells.
Abe A; Takano K; Seki N; Jitsukawa S; Yamamoto M; Takahashi H; Himi T
Mod Rheumatol; 2014 Nov; 24(6):949-52. PubMed ID: 24670136
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndrome.
Verstappen GM; Moerman RV; van Nimwegen JF; van Ginkel MS; Bijzet J; Mossel E; Vissink A; Hazenberg BPC; Arends S; Kroese FGM; Bootsma H
Rheumatology (Oxford); 2018 Oct; 57(10):1812-1821. PubMed ID: 29982712
[TBL] [Abstract][Full Text] [Related]
8. Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease?
Mavragani CP; Fragoulis GE; Rontogianni D; Kanariou M; Moutsopoulos HM
Arthritis Care Res (Hoboken); 2014 May; 66(5):773-7. PubMed ID: 25100215
[TBL] [Abstract][Full Text] [Related]
9. Clinical Performance of Immunonephelometric Assay and Chemiluminescent Immunoassay for Detection of IgG Subclasses in Chinese.
Qin Y; Jia Y; Liang C; Fu R; Liang Z; Wang Y; Feng M; Gao C; Luo J
J Clin Lab Anal; 2024 Apr; 38(8):e25033. PubMed ID: 38563457
[TBL] [Abstract][Full Text] [Related]
10. Salivary and serum soluble interleukin-2 receptor in primary Sjögren's syndrome.
Tishler M; Yaron I; Shirazi I; Levartovsky D; Yaron M
Arch Oral Biol; 1999 Apr; 44(4):305-8. PubMed ID: 10348356
[TBL] [Abstract][Full Text] [Related]
11. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance.
Kiyama K; Kawabata D; Hosono Y; Kitagori K; Yukawa N; Yoshifuji H; Omura K; Fujii T; Mimori T
Arthritis Res Ther; 2012 Apr; 14(2):R86. PubMed ID: 22531553
[TBL] [Abstract][Full Text] [Related]
12. Serum immunoglobulin G4 in Sjögren's syndrome: a pilot study.
Maślińska M; Wojciechowska B; Mańczak M; Kwiatkowska B
Rheumatol Int; 2020 Apr; 40(4):555-561. PubMed ID: 32062697
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
[TBL] [Abstract][Full Text] [Related]
14. Comorbid case of IgG4-related disease and primary Sjögren's syndrome.
Nakashima Y; Nakamura H; Horai Y; Hayashi T; Takagi Y; Nakamura T; Kawakami A
Mod Rheumatol; 2015 May; 25(3):462-7. PubMed ID: 24593168
[TBL] [Abstract][Full Text] [Related]
15. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic utility of labial salivary gland biopsy in IgG4-related disease.
Moriyama M; Ohta M; Furukawa S; Mikami Y; Tanaka A; Maehara T; Yamauchi M; Ishiguro N; Hayashida JN; Kawano S; Ohyama Y; Kiyoshima T; Nakamura S
Mod Rheumatol; 2016 Sep; 26(5):725-9. PubMed ID: 26873153
[TBL] [Abstract][Full Text] [Related]
17. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
18. The immunobiology and clinical characteristics of IgG4 related diseases.
Takahashi H; Yamamoto M; Tabeya T; Suzuki C; Naishiro Y; Shinomura Y; Imai K
J Autoimmun; 2012 Aug; 39(1-2):93-6. PubMed ID: 22341851
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of IgG4 and soluble interleukin-2 receptor in patients with coronary artery disease.
Sakamoto A; Ishizaka N; Saito K; Imai Y; Morita H; Koike K; Kohro T; Nagai R
Clin Chim Acta; 2012 Mar; 413(5-6):577-81. PubMed ID: 22146599
[TBL] [Abstract][Full Text] [Related]
20. Hyperviscosity in primary Sjögren's syndrome: clinical implications.
Hernández-Molina G; Bermúdez-Bermejo P
Int J Rheum Dis; 2017 Jan; 20(1):84-89. PubMed ID: 26807556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
